[Nitrofurantoin-induced lung disease: about two cases]

Rev Med Interne. 2008 Feb;29(2):149-51. doi: 10.1016/j.revmed.2007.06.016. Epub 2007 Jul 10.
[Article in French]

Abstract

Introduction: Nitrofurantoin is commonly used in the treatment of urinary tract infection and may cause a potential severe complication: interstitial lung diseases.

Case report: A 78-year-old and an 87-year-old woman treated with nitrofurantoin since respectively 10 months and 6 years developed cough and dyspnea. Antibiotics were ineffective and interstitial lung disease was found. Nitrofurantoin's stopping allowed a clinical and radiological improvement.

Conclusion: A good medical supervision is important when nitrofurantoin is prescribed for a long time. The treatment has to be stopped when respiratory symptoms appear to allow an improvement of the symptoms.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anti-Infective Agents, Urinary / adverse effects*
  • Cough / chemically induced
  • Dyspnea / chemically induced
  • Female
  • Humans
  • Lung Diseases, Interstitial / chemically induced*
  • Lung Diseases, Interstitial / physiopathology
  • Maximal Expiratory Flow Rate / drug effects
  • Nitrofurantoin / adverse effects*
  • Total Lung Capacity / drug effects
  • Vital Capacity / drug effects

Substances

  • Anti-Infective Agents, Urinary
  • Nitrofurantoin